Feline immunodeficiency. ABCD guidelines on prevention and management. - Wikidata - wikimedia - TriplyDB

Feline immunodeficiency. ABCD guidelines on prevention and management.

Feline immunodeficiency. ABCD guidelines on prevention and management.

http://www.wikidata.org/entity/Q34983862

about

Feline leukemia virus and feline immunodeficiency virus in Canada: recommendations for testing and management Pharmacological inhibition of feline immunodeficiency virus (FIV)Disparities in Spatial Prevalence of Feline Retroviruses due to Data Aggregation: A Case of the Modifiable Areal Unit Problem.Seroprevalence of feline immunodeficiency virus, feline leukaemia virus and Toxoplasma gondii in stray cat colonies in northern Italy and correlation with clinical and laboratory data.Feline immunodeficiency virus (FIV) env recombinants are common in natural infections.Comparison of the geographical distribution of feline immunodeficiency virus and feline leukemia virus infections in the United States of America (2000-2011)Anti-Inflammatory Therapy for Feline Immunodeficiency Virus Infection and Associated AIDS-Like Syndrome.Neutralising antibody response in domestic cats immunised with a commercial feline immunodeficiency virus (FIV) vaccine Contrasting clinical outcomes in two cohorts of cats naturally infected with feline immunodeficiency virus (FIV).Comparison of risk factors for seropositivity to feline immunodeficiency virus and feline leukemia virus among cats: a case-case study.An investigation of the breadth of neutralizing antibody response in cats naturally infected with feline immunodeficiency virus Rapid evolution of the env gene leader sequence in cats naturally infected with feline immunodeficiency virus.Feline immunodeficiency virus in South America.Evaluation of different antiretroviral drug protocols on naturally infected feline immunodeficiency virus (FIV) cats in the late phase of the asymptomatic stage of infection.Renal alterations in feline immunodeficiency virus (FIV)-infected cats: a natural model of lentivirus-induced renal disease changes.Percutaneous Ultrasound-guided Cholecystocentesis and Bile Analysis for the Detection of Platynosomum spp.-Induced Cholangitis in Cats.Efficacy of antiviral chemotherapy for retrovirus-infected cats: What does the current literature tell us?Molecular detection of viral agents in free-ranging and captive neotropical felids in Brazil.Systolic blood pressure, routine kidney variables and renal ultrasonographic findings in cats naturally infected with feline immunodeficiency virus.Risk factors and effect of selective removal on retroviral infections prevalence in Belgian stray cats.Dual-emission fluorescence resonance energy transfer (FRET) real-time PCR differentiates feline immunodeficiency virus subtypes and discriminates infected from vaccinated cats.Duration of antibody response following vaccination against feline immunodeficiency virus.Follow-up on long-term antiretroviral therapy for cats infected with feline immunodeficiency virus.Blood transfusion in cats: ABCD guidelines for minimising risks of infectious iatrogenic complications.Something old, something new: Update of the 2009 and 2013 ABCD guidelines on prevention and management of feline infectious diseases.Monitoring acute phase proteins in retrovirus infected cats undergoing feline interferon-ω therapy.The Use of Recombinant Feline Interferon Omega Therapy as an Immune-Modulator in Cats Naturally Infected with Feline Immunodeficiency Virus: New Perspectives.Efficacy of Antiviral Drugs against Feline Immunodeficiency Virus.Prevalence of selected infectious disease agents in stray cats in Catalonia, Spain.Applications of the FIV Model to Study HIV Pathogenesis.Seroprevalence of feline immunodeficiency virus and feline leukaemia virus in Australia: risk factors for infection and geographical influences (2011-2013).Lessons Learned in Developing a Commercial FIV Vaccine: The Immunity Required for an Effective HIV-1 Vaccine.Prevalence and risk factor analysis for feline haemoplasmas in cats from Northern Serbia, with molecular subtyping of feline immunodeficiency virus.

P2860

Q26829717-88872B21-D599-4D39-A60E-F44DCB2A0AC1 Q26995310-B6486616-67CB-4D63-902A-EEC90DFE0493 Q31004848-2565ADE4-C9A6-496C-B20E-8B64BFB2291A Q34154216-2117F282-D340-4533-A4B1-7B5A9B592D91 Q34270843-21757426-A93F-48DF-A1E1-571AD62ECF1B Q34536627-58A92566-7089-4C43-84A3-CC85F0B6070A Q34631387-9A8C01BD-0BEF-4152-916E-40465EC83474 Q35082956-CF000811-077F-4DC3-B114-772001654D94 Q35095616-3916BAA5-960D-4F8E-AD6D-B3D20AEC7BBA Q35095862-B8B02081-BA96-44BA-A528-3A00FC49701C Q35109028-8BDD2E73-AE5C-49B0-96B4-562E618ABB06 Q35182754-715785E6-037B-4419-8567-AD9D59DFD0D2 Q35942681-23E15F5C-3A56-4C9A-8D18-59FBB17F988A Q36096402-1DEDDE3C-587D-4011-9117-586FB15D0A86 Q36404150-87B103F1-F2C0-498E-B5CA-C5766AA58689 Q37020224-B53050C6-AFA5-4CC0-9D83-DFC891ECC5F8 Q38612672-1BBBCD1C-0C4B-4B19-9E87-D8F57E97A35B Q38693413-E823F682-99A5-421B-A258-CC2E0BC6A62F Q39680375-EBFBB587-A839-4079-8A22-577FF3B9510A Q40130488-8404D1FB-D730-4778-AAC2-3EC74A35E363 Q40345150-2B788329-F077-4CE0-84E2-35E533F1E354 Q40492566-7A997452-CC97-4AEF-8931-F18A4BD09509 Q41098894-6921C0A4-03FE-442B-AE07-C03276E3C298 Q41145116-704D69BC-6816-44DA-9E65-5F45C683BB5D Q41145132-38AEB8D8-7F47-4561-AD24-4457E16D5AEC Q42252898-D7058075-8AFA-4315-A288-8805ABCC394E Q43378634-11897EAD-5367-4B03-9ACA-D1FA09D0090E Q44742776-65335779-0C57-4375-8BA1-9BDC12146314 Q50890926-88981532-2D24-46BF-BEDA-EC4257333E82 Q52574472-F4A4F48A-A58A-4A12-8FE1-1AE62FCEDF95 Q53079099-D32710F9-EF48-4C7D-9C93-790476694861 Q54984932-CF1A68F8-0567-4096-AF0D-24675437AF8A Q55003846-A8F176A4-15B3-42D9-9744-6FC3C1AAB088

P2860

Feline immunodeficiency. ABCD guidelines on prevention and management.

http://www.wikidata.org/entity/Q34983862

description

2009 nî lūn-bûn

@nan

2009 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Feline immunodeficiency. ABCD guidelines on prevention and management.

@ast

Feline immunodeficiency. ABCD guidelines on prevention and management.

@en

Feline immunodeficiency. ABCD guidelines on prevention and management.

@nl

type

label

Feline immunodeficiency. ABCD guidelines on prevention and management.

@ast

Feline immunodeficiency. ABCD guidelines on prevention and management.

@en

Feline immunodeficiency. ABCD guidelines on prevention and management.

@nl

prefLabel

Feline immunodeficiency. ABCD guidelines on prevention and management.

@ast

Feline immunodeficiency. ABCD guidelines on prevention and management.

@en

Feline immunodeficiency. ABCD guidelines on prevention and management.

@nl

P1433

Q34983862-AF86F621-0E8C-47FB-B7D8-06E411E48730

P1476

Q34983862-5BAF5A34-7725-4300-83C1-A49BD0A6FAE1

P2093

Q34983862-06D82A9F-6DF9-48DC-A927-1B457ABA9F79

Q34983862-101FD316-BF78-46FC-B7EE-FB29DFD3C67C

Q34983862-131FDF7A-A294-45D8-8631-F68EC710B5F2

Q34983862-80E681FE-E382-4E03-9F52-90295C9ABF68

Q34983862-8AF2458F-68D1-4752-9A75-257CA4B79254

Q34983862-A92F6A83-85F1-4EAF-B4FF-9D4389F6BE2A

Q34983862-AC225E82-1C7D-457F-8F19-B982C3B0AC30

Q34983862-F3A098AA-B899-4970-B114-3630C1DEB540

P2860

Q34983862-004F69A7-EC3C-49A3-9E8F-EDC97944BE12

Q34983862-05610216-E258-4292-92CE-F51069B27E51

Q34983862-06D220A8-A8F9-4A06-BE78-68F3C672DD49

Q34983862-089D0FE3-BCF7-4D40-9D45-C25E23EB0957

Q34983862-0900548E-CF03-4D3A-AC0B-C0D087AC055A

Q34983862-0C1913CC-AAB8-4C79-8D73-439F0B61DD9B

Q34983862-162E6A72-B617-40DA-B559-9059ABF11020

Q34983862-1B8E4040-79BE-417C-A363-93AFEECADDCC

Q34983862-240FE055-28F0-48AF-B9F3-F8BFBD4E1536

Q34983862-313C9347-C29D-4AFE-A8BA-3F7A3E378F48

P304

Q34983862-A406AF27-B619-4E07-930D-29D4D21A1BD6

P31

Q34983862-15DE2B2A-7C7B-4B45-B147-9CD1A7E237F0

P356

Q34983862-DE76CDBD-A637-4143-A08B-5DB9032DD907

P433

Q34983862-190C72B5-DDCE-4778-9CB2-C9AD0FB1404B

P478

Q34983862-C4CB75D8-3CC9-4D30-A405-F6914C399112

P50

Q34983862-55B73888-260B-48F6-810B-D7E8D1DA52A6

Q34983862-5C9495F9-600E-47C8-A305-A60745474D2A

Q34983862-6350F0E0-6287-41B3-BC10-000852FD35CC

Q34983862-70299269-74B2-4941-8179-5A728DED2727

Q34983862-804524EC-7490-47C7-B53E-D236679E1CF0

Q34983862-94CA6672-1566-4710-B8F5-7BE5576080E8

Q34983862-CA59994B-0F59-49B6-8844-EB551C83F7CA

Q34983862-E6292978-12DD-4010-8826-E3240BFA6BDB

P577

Q34983862-6C1D4AE8-D32D-43C2-AE77-50FDAA7BEBB5

P698

Q34983862-2ACC5312-3708-4898-91C2-F986D1BB5924

P356

J.JFMS.2009.05.006

P1433

Journal of Feline Medicine and Surgery

P1476

Feline immunodeficiency. ABCD guidelines on prevention and management

@en

P2093

Albert Lloret

http://www.w3.org/2001/XMLSchema#string

Diane Addie

http://www.w3.org/2001/XMLSchema#string

Fulvio Marsilio

http://www.w3.org/2001/XMLSchema#string

Hans Lutz

http://www.w3.org/2001/XMLSchema#string

Herman Egberink

http://www.w3.org/2001/XMLSchema#string

Marian C Horzinek

http://www.w3.org/2001/XMLSchema#string

Tim Gruffydd-Jones

http://www.w3.org/2001/XMLSchema#string

Uwe Truyen

http://www.w3.org/2001/XMLSchema#string

P2860

Use of CD134 as a primary receptor by the feline immunodeficiency virus.

Disseminated Mycobacterium genavense infection in a FIV-positive cat.

Immunomodulation and therapeutic effects of the oral use of interferon-alpha: mechanism of action.

Human immunodeficiency virus and AIDS: insights from animal lentiviruses

Isolation of a T-lymphotropic virus from domestic cats with an immunodeficiency-like syndrome.

Nucleotide sequence analysis of feline immunodeficiency virus: genome organization and relationship to other lentiviruses.

Feline immunodeficiency virus infection.

Feline immunodeficiency virus vaccine: implications for diagnostic testing and disease management.

Differential utilization of CD134 as a functional receptor by diverse strains of feline immunodeficiency virus.

Vaccine protection against feline immunodeficiency virus: setting the challenge.

P304

575-584

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.JFMS.2009.05.006

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P50

Katrin Hartmann

Maria Grazia Pennisi

Corine Boucraut-Baralon

Margaret J Hosie

P577

2009-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

19481037

http://www.w3.org/2001/XMLSchema#string